Search

everythinglearnresearchcommunity

for

Search:↓

Pegylated interferon-alpha 2a can cause a rare nerve disorder, but early treatment can lead to full recovery.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.

Lichen planopilaris patients are more likely to have hypothyroidism.

Most patients with Cutaneous Lupus Erythematosus are young females, and dermatologists play a key role in diagnosis.

High lactate dehydrogenase activity is not necessary for the growth of squamous cell carcinoma.

Lung immune cells can be trained to better fight infections after a virus.

Chemotherapy can cause skin problems like hair loss, mouth sores, and skin darkening, and recognizing these can affect treatment decisions.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Chronic granulomatous disease may be linked to developing systemic lupus erythematosus.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

Vinblastine can help treat childhood ITP but may cause reversible side effects.

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

All parts of the CLASI-A score are important for assessing skin activity in cutaneous lupus erythematosus.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

A high neutrophil-to-lymphocyte ratio may predict poor response to hair loss treatment.

CD8+ virtual memory T cells may cause hair loss in alopecia areata.

Relatives of lupus patients show signs of immune system activity but not full-blown lupus.

Immunocompromised patients can develop skin and hair issues due to a virus.

A woman with chronic hepatitis C had a rare skin condition linked to her illness.

IV cyclophosphamide effectively treated severe lupus nephritis in Indian patients, but longer follow-up is needed.

Talquetamab may cause hair loss and skin issues.

Inhibiting TYK2 can restore hair growth in alopecia areata.

ICI therapy increases the risk of gastrointestinal and endocrine issues in psoriasis patients.

Frunevetmab injections in cats can cause severe itching and skin lesions.

Immune therapy for cancer can cause hair loss scars in some patients.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

Topical squaric acid dibutylester worsened discoid lupus erythematosus in a patient.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Sudden hair whitening may be linked to immune system activity.